Philips (NYSE:PHG) has issued corrections for some of its Trilogy Evo ventilator platforms due to multiple issues.
Using non-pneumatic nebulizers with the ventilators can lead to under-delivery of therapy to patients, the company said.
(RTTNews) - Philips Respironics, affiliated to Dutch consumer electronics giant, announced additional usage instructions for Trilogy Evo Ventilators related to use of in-line nebulizers. The company ...
Philips has issued a voluntary recall of software for its Trilogy Evo ventilator series and a warning to patients not to use non-pneumatic nebulizers with the devices, as they may not deliver the ...
On Tuesday, Koninklijke Philips N.V. (NYSE:PHG) issued a correction related to the Software Version used in Trilogy Evo, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal ventilators to resolve ...
Review five recent medical device recalls flagged by the FDA affecting ventilators, implants, anesthesia systems ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results